Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo i...

Multilingual Wikipedia

In June 2020 the work Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo i... was on the 807,608th place in the ranking of the most reliable and popular publications with DOI number in multilingual Wikipedia from readers' point of view (PR-score). If we consider only frequency of appearance of this source in references of Wikipedia articles (F-score), this work was on the 946,574th place in June 2020. From Wikipedians' point of view, "Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo i..." is the 361,304th most reliable publication with DOI number in different language versions of Wikipedia (AR-score).

PR-score:
807,608th place
866
-500
AR-score:
361,304th place
733
0
F-score:
946,574th place
1
0

English Wikipedia (en)

PR-score:
680,255th place
866
-500
AR-score:
284,099th place
733
0
F-score:
768,642nd place
1
0

BestRef shows popularity and reliability scores for sources in references of Wikipedia articles in different languages. Data extraction based on complex method using Wikimedia dumps. To find the most popular and reliable sources we used information about over 200 million references of Wikipedia articles. More details...